These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18342376)

  • 1. The Wnt/frizzled/GSK-3 beta pathway: a novel therapeutic target for cardiac hypertrophy.
    Blankesteijn WM; van de Schans VA; ter Horst P; Smits JF
    Trends Pharmacol Sci; 2008 Apr; 29(4):175-80. PubMed ID: 18342376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy.
    van de Schans VA; van den Borne SW; Strzelecka AE; Janssen BJ; van der Velden JL; Langen RC; Wynshaw-Boris A; Smits JF; Blankesteijn WM
    Hypertension; 2007 Mar; 49(3):473-80. PubMed ID: 17210832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
    Hardt SE; Tomita H; Katus HA; Sadoshima J
    Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac hypertrophy and the Wnt/Frizzled pathway.
    Cingolani OH
    Hypertension; 2007 Mar; 49(3):427-8. PubMed ID: 17210831
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning.
    Barandon L; Dufourcq P; Costet P; Moreau C; Allières C; Daret D; Dos Santos P; Daniel Lamazière JM; Couffinhal T; Duplàa C
    Circ Res; 2005 Jun; 96(12):1299-306. PubMed ID: 15920021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evolutionary conserved role of Wnt signaling in stem cell fate decision.
    Teo R; Möhrlen F; Plickert G; Müller WA; Frank U
    Dev Biol; 2006 Jan; 289(1):91-9. PubMed ID: 16309665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Wnt/frizzled pathway in cardiovascular development and disease: friend or foe?
    van de Schans VA; Smits JF; Blankesteijn WM
    Eur J Pharmacol; 2008 May; 585(2-3):338-45. PubMed ID: 18417121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer.
    Liss MA; Schlicht M; Kahler A; Fitzgerald R; Thomassi T; Degueme A; Hessner M; Datta MW
    Cancer Genomics Proteomics; 2010; 7(5):245-52. PubMed ID: 20952759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
    Oloumi A; Syam S; Dedhar S
    Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRH and SRIF have opposite effects on the Wnt/β-catenin signalling pathway through PKA/GSK-3β in corticotroph pituitary cells.
    Khattak MN; Buchfelder M; Kleindienst A; Schöfl C; Kremenevskaja N
    Cancer Invest; 2010 Oct; 28(8):797-805. PubMed ID: 20690801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt/Frizzled pathway as a therapeutic target for cardiac hypertrophy: where do we stand?
    ter Horst P; Smits JF; Blankesteijn WM
    Acta Physiol (Oxf); 2012 Jan; 204(1):110-7. PubMed ID: 21624093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
    Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
    J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/beta-catenin pathway.
    Moon RT
    Sci STKE; 2005 Feb; 2005(271):cm1. PubMed ID: 15713948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Wnt signaling and glucocorticoid-induced osteoporosis].
    Ohnaka K
    Clin Calcium; 2006 Nov; 16(11):1812-6. PubMed ID: 17079847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells.
    Etheridge SL; Spencer GJ; Heath DJ; Genever PG
    Stem Cells; 2004; 22(5):849-60. PubMed ID: 15342948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.
    Kulkarni NH; Onyia JE; Zeng Q; Tian X; Liu M; Halladay DL; Frolik CA; Engler T; Wei T; Kriauciunas A; Martin TJ; Sato M; Bryant HU; Ma YL
    J Bone Miner Res; 2006 Jun; 21(6):910-20. PubMed ID: 16753022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling.
    Naito AT; Akazawa H; Takano H; Minamino T; Nagai T; Aburatani H; Komuro I
    Circ Res; 2005 Jul; 97(2):144-51. PubMed ID: 15994435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.
    Calvisi DF; Conner EA; Ladu S; Lemmer ER; Factor VM; Thorgeirsson SS
    J Hepatol; 2005 Jun; 42(6):842-9. PubMed ID: 15885355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling.
    Rao AS; Kremenevskaja N; Resch J; Brabant G
    Eur J Endocrinol; 2005 Dec; 153(6):929-38. PubMed ID: 16322400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.